Register

Please register so we can remember your preferences, like your favourite suppliers and preferred news & events.


Supplier Login



New user? Register as a supplier


Forgot password?


My Account

Latest News in the pharma Industry

All

Novartis achieves regulatory milestone for AMG 334 in migraine prevention with EMA filing acceptance

Novartis achieves regulatory milestone for AMG 334 in migraine prevention with EMA filing acceptance

21 Jun 2017

AMG 334 (erenumab) is the first anti-CGRP monoclonal antibody developed for migraine prevention to receive EMA regulatory filing acceptance.

Read more 
Accelerating freeze drying cycle development with just seven vials

Accelerating freeze drying cycle development with just seven vials

21 Jun 2017

Compared with other small-scale R&D freeze dryers, the LyoCapsule lyophilizer is the only system that can monitor and independently control the wall temperature via use of the center vial product temperature.

Read more 
Takeda completes new manufacturing facilities at the Oranienburg site in Germany

Takeda completes new manufacturing facilities at the Oranienburg site in Germany

20 Jun 2017

The manufacture of solid dosage form pharmaceutical products would be transferred from the Osaka Plant to the new plant.

Read more 
QuVa Pharma announces availability of sodium bicarbonate syringe

QuVa Pharma announces availability of sodium bicarbonate syringe

20 Jun 2017

Compounded Sodium Bicarbonate PF 8.4% 50mEq per syringe is expected to help alleviate chronic drug shortage impacting the nation's hospitals.

Read more 
Glenmark Pharmaceuticals licenses small molecule oncology compound from APC Therapeutics to expand IO portfolio

Glenmark Pharmaceuticals licenses small molecule oncology compound from APC Therapeutics to expand IO portfolio

20 Jun 2017

The compound has the potential to be used as a monotherapy or in combination with approved therapies to address unmet needs in cancer treatment.

Read more 
Merck Ventures creates new immuno-oncology company iOnctura

Merck Ventures creates new immuno-oncology company iOnctura

20 Jun 2017

iOnctura is set up to develop a pipeline of assets targeting immunosuppression in the tumour microenvironment.

Read more 
FDA accepts Amgen's sBLA to expand indication for Xgeva to include multiple myeloma patients

FDA accepts Amgen's sBLA to expand indication for Xgeva to include multiple myeloma patients

19 Jun 2017

Xgeva is indicated for the prevention of skeletal-related events in patients with bone metastases from solid tumours and is the number one prescribed agent by oncologists for this indication in the US.

Read more 
J&J completes acquisition of Actelion

J&J completes acquisition of Actelion

19 Jun 2017

Actelion will now become part of the Janssen Pharmaceutical Companies of J&J.

Read more 
Sandoz receives approval in Europe for Rixathon to treat blood cancers and immunological diseases

Sandoz receives approval in Europe for Rixathon to treat blood cancers and immunological diseases

19 Jun 2017

Sandoz now has four biosimilars approved in Europe - more than any other company.

Read more 
FDA updates on Pfizer drug shortages

FDA updates on Pfizer drug shortages

18 Jun 2017

Pfizer says shortages caused by manufacturing, distribution and third party delays.

Read more 
BMS to sell manufacturing facility in Swords, Ireland to SK Biotek

BMS to sell manufacturing facility in Swords, Ireland to SK Biotek

16 Jun 2017

Company shifts manufacturing focus in Ireland to reflect growing biologics portfolio with ongoing investment in Cruiserath biologics facility.

Read more 
Merck presses the pause button on Keytruda trials

Merck presses the pause button on Keytruda trials

16 Jun 2017

The pause is to allow for additional information to be collected to better understand more reports of death in the Keytruda groups.

Read more 

Are you a supplier? Here's what we can do for you

Register now